82 related articles for article (PubMed ID: 7146070)
1. Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Part 2.
Mager PP; Das Gupta S
Pharmazie; 1982 Aug; 37(8):607-8. PubMed ID: 7146070
[No Abstract] [Full Text] [Related]
2. Quantitative structure-reactivity and structure-toxicity relationships of reactivators of phosphylated acetylcholinesterase.
Mager PP
Pharmazie; 1981 Jun; 36(6):450-1. PubMed ID: 7279998
[No Abstract] [Full Text] [Related]
3. Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Part 3.
Mager PP
Pharmazie; 1982 Nov; 37(11):800-1. PubMed ID: 7163364
[No Abstract] [Full Text] [Related]
4. [Structure-activity relationships in acetylcholinesterase reactivators inhibited by organophosphorus compounds. IV. N-hydroxyimidazole-3-oxides and their quaternary salts].
Franchetti P; Grifantini M; Lucarelli C; Stein ML
Farmaco Sci; 1972 Jan; 27(1):46-59. PubMed ID: 4353914
[No Abstract] [Full Text] [Related]
5. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 6. 2-Hydroxyiminomethylimidazolium iodides.
Grifantini M; Martelli S; Stein ML
J Med Chem; 1973 Aug; 16(8):937-9. PubMed ID: 4745838
[No Abstract] [Full Text] [Related]
6. Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase.
Acharya J; Gupta AK; Dubey DK; Raza SK
Eur J Med Chem; 2009 Mar; 44(3):1335-40. PubMed ID: 18396353
[TBL] [Abstract][Full Text] [Related]
7. [Effect of mono- and bisammoniumacetonoxime salts on acetylcholinesterase and DFP].
Reiner R; Scherer A
Arzneimittelforschung; 1973 Aug; 23(8):1041-4. PubMed ID: 4801024
[No Abstract] [Full Text] [Related]
8. [The action of cholinesterase reactivators on the body not related to the recovery of the activity of phosphorylated acetylcholinesterase].
Shorokhov IuA; Zatsepin EP; Androsov NS
Eksp Klin Farmakol; 1993; 56(4):62-6. PubMed ID: 8106061
[No Abstract] [Full Text] [Related]
9. Effective bisquaternary reactivators of tabun-inhibited AChE.
Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
[TBL] [Abstract][Full Text] [Related]
10. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
Musilova L; Kuca K; Jung YS; Jun D
Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three enzymatic models for evaluation of reactivators of organophosphorus ester inhibited acetylcholinesterase.
Miller A; Nolen HW; Jackson SE; Howd RA; Harris RN; Bedford CD
Proc West Pharmacol Soc; 1984; 27():297-301. PubMed ID: 6494168
[No Abstract] [Full Text] [Related]
12. [Hydroxyiminoacetone-like reactivators of phosphorylated cholinesterases. Structure-activity relationships via molecular modelling].
Bonnafous M; Stigliani JL; Adam Y; Grassy G; Boudet Dalbin R; Teulade JC
Farmaco; 1989 Feb; 44(2):141-64. PubMed ID: 2775412
[TBL] [Abstract][Full Text] [Related]
13. Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes: synthesis and biological activity.
Chennamaneni SR; Vobalaboina V; Garlapati A
Bioorg Med Chem Lett; 2005 Jun; 15(12):3076-80. PubMed ID: 15908205
[TBL] [Abstract][Full Text] [Related]
14. Comments on "Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI 6".
Theirmann H; Worek F; Eyer P
Toxicol Mech Methods; 2009 May; 19(4):334; author reply 335. PubMed ID: 19778225
[No Abstract] [Full Text] [Related]
15. Force spectroscopy between acetylcholine and single acetylcholinesterase molecules and the effects of inhibitors and reactivators studied by atomic force microscopy.
Yingge Z; Chunli B; Chen W; Delu Z
J Pharmacol Exp Ther; 2001 May; 297(2):798-803. PubMed ID: 11303072
[TBL] [Abstract][Full Text] [Related]
16. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
17. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis of reactivators of phosphorylated acetylcholinesterase of bis-pyridiniumdialdoxime type with a 3-oxapentane connecting chain and their testing in vitro on a model of the enzyme inhibited by chlorpyrifos and methylchlorpyrifos].
Musílek K; Kuca K; Jun D; Dohnal V; Kim TH; Jung YS; Dolezal M
Ceska Slov Farm; 2006 May; 55(3):115-9. PubMed ID: 16838488
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
[TBL] [Abstract][Full Text] [Related]
20. Development of a dynamic model for real-time determination of membrane-bound acetylcholinesterase activity upon perfusion with inhibitors and reactivators.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):358-65. PubMed ID: 16725113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
